Souza, Rimenez R.
Powers, Mark B.
Rennaker, Robert L.
McIntyre, Christa K.
Hays, Seth A.
Kilgard, Michael P.
Funding for this research was provided by:
Defense Advanced Research Projects Agency (N66001-15-2-4057)
Article History
Received: 1 April 2022
Accepted: 12 September 2022
First Online: 3 October 2022
Competing interests
: MPK has a financial interest in MicroTransponder Inc., which is developing VNS for stroke. MPK and CKM are authors of a patent entitled ‘Enhancing Fear Extinction using Vagus Nerve Stimulation’. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.